News & AnalysisRona Therapeutics scores $33m Series ARona Therapeutics, provider of RNA therapeutics, has closed $33 million in Series A financing.ByIris Dorbian7 April 2022•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs